Welcome
Support Centre
11 February 2012 
Current Controlled Trials - Clinical Trials
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   news
Introduction
English introduction Introduction en français Deutsche einleitung
Introducción española Introduzione in italiano
 
Find trials
active registers
mental health register
archived registers
all registers
tips on searching
 
 
Information
about mRCT
mRCT FAQs

DISCLAIMER
The site should not be used to diagnose or treat a health problem. Please consult your doctor.
Terms & conditions

DUPLICATION
Your search result may contain a number of different records for the same trial. This occurs when the same trial is listed in more than one register.

[ ...Back to search results ] [ Print-friendly version ]
An investigation of the effectiveness of a Mobilisation with Movement (MWM) technique for Lateral Epicondylagia on pain and function in clinical practice
Source of recordUK Trials
ISRCTNISRCTN89551492
Date ISRCTN assigned28/09/2007
Local reference number(s)N0046187175
Public titleAn investigation of the effectiveness of a Mobilisation with Movement (MWM) technique for Lateral Epicondylagia on pain and function in clinical practice
Scientific title
AcronymN/A
Disease/condition/study domainMusculoskeletal Diseases: Tennis elbow
Study hypothesisDoes the use of a Mobilisation with Movement technique improve pain and function in patients with chronic Lateral Epicondylagia (Tennis Elbow) when used in a clinical setting?
Design/methodologyRandomised controlled trial
Research ethics reviewNot provided at time of registration
Countries of trialUnited Kingdom
Participants - inclusion criteria1. Patients diagnosed with chronic lateral epicondylagia (this is a clinical diagnosis based on previously established criteria, i.e. pain over the lateral side of the elbow provoked by palpitation of the lateral epicondyle region and gripping tasks, pain over the lateral epicondyle during either resisted static contraction or stretching of the forearm extensor muscles, and symptoms of greater than 6 weeks duration)
2. Both male and female patients
3. Adults ie patients over 18 years old
Participants - exclusion criteriaNot provided at time of registration
Patient information material
Anticipated start date01/03/2006
Anticipated end date01/05/2007
Status of trialCompleted
Target number of participantsNot provided at time of registration
InterventionsParticipants will be selected from a population of all patients referred to the Physiotherapy Department at Solihull Hospital with a diagnosis of Lateral Epicondylagia, Lateral Epincondylitis, Tennis Elbow or lateral elbow pain.

In order to assess the effectiveness of the technique, a randomised controlled trial is proposed. This will involve randomly putting patients into two groups, ie, a treatment group and a control group.

All patients will receive a thorough assessment of their elbow problem and asked to answer questions which will both evaluate their suitability for inclusion or need for exclusion from the trial and provide descriptive information allowing for comparison of the characteristics of the two groups. Baseline values for pain-free grip strength and the Patient-Rated Forearm Evaluation Questionnaire (PRFEQ) will be collected. Both pain-free grip strength and the PRFEQ are assessment tools which have been shown to be valid and reliable in assessing pain and function in patients with Lateral Epicondylagia (Tennis Elbow). Pain-free grip strength will be measured using a hand grip dynamometer with a digital display. The value on the display will be read by a Physiotherapy Assistant in order to prevent bias by the researcher. Patients will be asked to fill out the questionnaire (PRFEQ) themselves. This is a 15 item questionnaire which takes about 5 minutes to complete. In order to prevent bias by the researcher, the randomisation process will be carried out by reception staff at Solihull Hospital, who will select a sealed envelope from a box. In the envelopes there will be equal numbers of cards stating 'group 1' and 'group 2'. The randomisation process should maximise the likelihood of the two groups being equal, eg age, gender, hand dominance, duration of symptoms.

Group 1 will be the treatment group. They will asked to attend the physiotherapy department twice a week for three weeks.
Group 2 will be the control group. They will simply be given an appointment to attend for reassessment 3 weeks later.

At the final attendance within the study, both groups will have pain-free strength re-measured and be asked to repeat the questionnaire (PRFEQ).
Following their involvement in the trial, regardless of the group they are assigned to, all patients for whom further treatment is necessary will be offered further appointments.
Primary outcome measure(s)Outcome measures for the study are Pain-free grip strength and the Patient-Related Forearm Evaluation Questionnaire (PRFEQ). Each of these outcome measures has been shown to be a valid and reliable method of both pain and function.
Secondary outcome measure(s)Not provided at time of registration
Sources of fundingHeart of England NHS Foundation Trust
Sponsor nameRecord Provided by the NHSTCT Register - 2007 Update - Department of Health
Sponsor detailsThe Department of Health, Richmond House, 79 Whitehall
London
United Kingdom
SW1A 2NL
Sponsor telephone+44 (0)20 7307 2622
Sponsor fax+44
Sponsor emaildhmail@doh.gsi.org.uk
Sponsor websitehttp://www.dh.gov.uk/Home/fs/en
Contact nameMs Alison Bartlett
Contact detailsPhysiotherapy Department
Solihull Hospital


Solihull
United Kingdom
B91 2JL
Contact telephone+44 0121 424 5446
Contact fax+44
Contact emailalison.bartlett@heartofengland.nhs.uk
More informationFor more up-to-date information please go to the ISRCTN link below.
Link to record in ISRCTN RegisterISRCTN89551492
Date last extracted from ISRCTN register17/04/2008
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2012 Current Controlled Trials Ltd. Part of Springer Science+Business Media. | terms & conditions | privacy statement


BioMed Central